PT-141

Molecular Overview:

PT-141 is a synthetic melanocortin receptor agonist investigated for its role in neurological and receptor-mediated signaling pathways. Experimental studies have explored its interaction with melanocortin receptors associated with neuroendocrine communication and behavioral signaling processes.

Key areas of investigation include:

• Melanocortin receptor signaling pathways
• Neuroendocrine communication mechanisms
• Central nervous system receptor activity
• Behavioral signaling models
• Receptor-mediated molecular interactions

These areas position PT-141 as a compound of interest in neurobiology, receptor signaling, and experimental neuroscience research.

Mechanisms of Action (Investigational):

Melanocortin Receptor Activity:

PT-141 has been evaluated for its interaction with melanocortin receptor pathways in controlled laboratory environments.

Neurological Signaling:

Research has explored the peptide’s effects on receptor-mediated communication processes associated with neural signaling.

Neuroendocrine Pathway Modulation:

Studies suggest potential involvement in neuroendocrine regulatory signaling pathways relevant to behavioral research models.

Observed Research Effects (Non-Clinical):

Findings from experimental models have suggested potential associations with:

• Melanocortin receptor pathway modulation
• Neurological signaling interactions
• Neuroendocrine communication activity
• Receptor-mediated signaling changes
• Behavioral pathway responses

These observations are preliminary and limited to controlled research environments.

Common Research Applications:

PT-141 is utilized in laboratory investigations involving:
• Melanocortin receptor studies
• Neuroendocrine signaling analysis
• Behavioral pathway research
• Central nervous system signaling investigations
• Experimental receptor biology
• Molecular communication pathway studies

Legal Disclaimer:

This product is intended for research use only. Not for human consumption, medical use, or veterinary application. This compound has not been evaluated by the U.S. Food and Drug Administration for safety or efficacy. All use must comply with applicable laws and regulations.

All products sold on this site are for research and development use only. They are not intended for human or animal use.
 

The statements on this website have not been evaluated by the US Food and Drug Administration (FDA). Our products and content are not intended to diagnose, treat, cure, or prevent any disease.

Tides Peptides is a chemical supplier, not a compounding pharmacy or a chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act.

• Peptide Sequence: Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH
• Molecular Formula: C50H68N14O10
• Molecular Weight: 1025.2 g/mol

1. What is PT-141 and why does it matter?

PT-141 is a synthetic peptide investigated in research models related to melanocortin receptor activity and neurological signaling.

• Studied in relation to receptor-mediated pathways
• Evaluated for interactions with neuroendocrine signaling
• Utilized in experimental neuroscience and molecular biology research

2. What are the benefits of PT-141?

• Associations with receptor signaling modulation
• Observations involving neuroendocrine pathway activity
• Interactions with neurological communication systems
• Effects in behavioral signaling models
• Activity in melanocortin receptor research

These findings are limited to preclinical and laboratory research.

3. What is PT-141 used for?

Neuroscience Research:

• Melanocortin receptor investigations
• Behavioral pathway analysis
• Experimental neuroendocrine studies

Cellular & Molecular Research:

• Receptor-mediated signaling studies
• Neurological communication pathway research
• Molecular interaction analysis

White Papers:

https://pubmed.ncbi.nlm.nih.gov/11356787/
(Study examining melanocortin receptor agonists and PT-141 related signaling activity.)

https://pubmed.ncbi.nlm.nih.gov/16022988/
(Research investigating PT-141 and melanocortin-mediated neurological pathways.)

https://pubmed.ncbi.nlm.nih.gov/12711827/
(Experimental study involving melanocortin receptor interactions and neuroendocrine signaling.)

https://pubmed.ncbi.nlm.nih.gov/15134803/
(Research discussing melanocortin agonists and receptor-mediated behavioral signaling pathways.)

https://pubmed.ncbi.nlm.nih.gov/18635553/
(Study evaluating PT-141 related receptor activity and central nervous system interactions.)

https://pmc.ncbi.nlm.nih.gov/articles/PMC5143778/
(Comprehensive review of melanocortin receptors, signaling pathways, and peptide agonists.)

https://pubmed.ncbi.nlm.nih.gov/23657457/
(Review covering melanocortin receptor biology and peptide-based signaling research.)